Add this topic to your myFT Digest for news straight to your inbox
By using CDOs to aid medical research, Wall Street might improve its image
Changing the chief executive is the easy part
Share price falls 6% in London trading
Expect the shares to remain in the doldrums until a fresh strategy is hammered out
London-listed pharmaceutical group’s shareholders are not happy with more of the same
UK banks have a duty to establish whether clients came by their wealth honestly
If British drugmaker’s share buy-backs continue, investors should be worried
International Edition